NextCure agrees to merge with Avere Therapeutics in $320 million PIPE transaction
NextCure, Inc. entered into a merger agreement with Avere Therapeutics, Inc. on July 14, 2026, whereby Avere will merge into NextCure subsidiaries and…
$320M
Company
SEC filing news and material events for NextCure, Inc., briefed from primary-source filings.
1 story
NextCure, Inc. entered into a merger agreement with Avere Therapeutics, Inc. on July 14, 2026, whereby Avere will merge into NextCure subsidiaries and…